Contineum Therapeutics, Inc.

Q2 2026 13F Holders

Symbol
CTNM
CUSIP
21217B100
Type
Equity
Class
CL A
Num filings
104
Total reported value, excl. options
$501 M
Manager Report Date Value ($000) Shares Option Type